Cargando…

Three donor site dressings in pediatric split-thickness skin grafts: study protocol for a randomised controlled trial

BACKGROUND: For children requiring split-thickness skin grafting for burn injury, the optimum donor site dressing is an ongoing subject of debate. The most common dressings in use, both regionally and worldwide, are calcium alginates. We will compare an alginate with two other dressings, all of whic...

Descripción completa

Detalles Bibliográficos
Autores principales: McBride, Craig A, Kimble, Roy M, Stockton, Kellie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335760/
https://www.ncbi.nlm.nih.gov/pubmed/25887128
http://dx.doi.org/10.1186/s13063-015-0557-9
_version_ 1782358392346509312
author McBride, Craig A
Kimble, Roy M
Stockton, Kellie
author_facet McBride, Craig A
Kimble, Roy M
Stockton, Kellie
author_sort McBride, Craig A
collection PubMed
description BACKGROUND: For children requiring split-thickness skin grafting for burn injury, the optimum donor site dressing is an ongoing subject of debate. The most common dressings in use, both regionally and worldwide, are calcium alginates. We will compare an alginate with two other dressings, all of which are in current use in the Pegg Leditschke Paediatric Burns Centre (PLPBC), to determine which dressing performs the best. METHODS/DESIGN: This is a randomised, prospective single center parallel three-arm trial comparing three donor site wound (DSW) dressings: Algisite™ M, a calcium alginate dressing; Cuticerin™, a smooth acetate gauze impregnated with water-repellent ointment (petrolatum, paraffin and Eucerite®) and Sorbact®, a gauze mesh coated with a dialkylcarbamoyl chloride (DACC) and amorphous hydrogel. Primary outcomes are days to complete DSW healing, and pain. Previously validated measures will be used for all outcomes. Secondary outcomes are: itch; scar appearance at three, six and 12 months; ease of dressing application and removal and dressing costs and utility. Results will be analysed on an intention-to-treat basis. Donor site thickness will be measured with a small biopsy from the center of the graft, to document the depth of the DSW across the groups. DISCUSSION: This study will provide comprehensive short- and long-term data on DSW dressings in pediatric split-thickness skin grafting. The best-performing dressing will become the preferred dressing for the PLPBC. We will provide rigorous data against which other dressings can be compared in future, recognising that alginates are the most common DSW dressing currently in use. Our study design replicates a real-world scenario in order to identify clinically significant differences between the three dressings. TRIAL REGISTRATION: This trial was prospectively registered on 8 April 2014 with the Australia and New Zealand Clinical Trials Register (identifier: ACTRN12614000380695). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13063-015-0557-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4335760
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43357602015-02-21 Three donor site dressings in pediatric split-thickness skin grafts: study protocol for a randomised controlled trial McBride, Craig A Kimble, Roy M Stockton, Kellie Trials Study Protocol BACKGROUND: For children requiring split-thickness skin grafting for burn injury, the optimum donor site dressing is an ongoing subject of debate. The most common dressings in use, both regionally and worldwide, are calcium alginates. We will compare an alginate with two other dressings, all of which are in current use in the Pegg Leditschke Paediatric Burns Centre (PLPBC), to determine which dressing performs the best. METHODS/DESIGN: This is a randomised, prospective single center parallel three-arm trial comparing three donor site wound (DSW) dressings: Algisite™ M, a calcium alginate dressing; Cuticerin™, a smooth acetate gauze impregnated with water-repellent ointment (petrolatum, paraffin and Eucerite®) and Sorbact®, a gauze mesh coated with a dialkylcarbamoyl chloride (DACC) and amorphous hydrogel. Primary outcomes are days to complete DSW healing, and pain. Previously validated measures will be used for all outcomes. Secondary outcomes are: itch; scar appearance at three, six and 12 months; ease of dressing application and removal and dressing costs and utility. Results will be analysed on an intention-to-treat basis. Donor site thickness will be measured with a small biopsy from the center of the graft, to document the depth of the DSW across the groups. DISCUSSION: This study will provide comprehensive short- and long-term data on DSW dressings in pediatric split-thickness skin grafting. The best-performing dressing will become the preferred dressing for the PLPBC. We will provide rigorous data against which other dressings can be compared in future, recognising that alginates are the most common DSW dressing currently in use. Our study design replicates a real-world scenario in order to identify clinically significant differences between the three dressings. TRIAL REGISTRATION: This trial was prospectively registered on 8 April 2014 with the Australia and New Zealand Clinical Trials Register (identifier: ACTRN12614000380695). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13063-015-0557-9) contains supplementary material, which is available to authorized users. BioMed Central 2015-02-08 /pmc/articles/PMC4335760/ /pubmed/25887128 http://dx.doi.org/10.1186/s13063-015-0557-9 Text en © McBride et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
McBride, Craig A
Kimble, Roy M
Stockton, Kellie
Three donor site dressings in pediatric split-thickness skin grafts: study protocol for a randomised controlled trial
title Three donor site dressings in pediatric split-thickness skin grafts: study protocol for a randomised controlled trial
title_full Three donor site dressings in pediatric split-thickness skin grafts: study protocol for a randomised controlled trial
title_fullStr Three donor site dressings in pediatric split-thickness skin grafts: study protocol for a randomised controlled trial
title_full_unstemmed Three donor site dressings in pediatric split-thickness skin grafts: study protocol for a randomised controlled trial
title_short Three donor site dressings in pediatric split-thickness skin grafts: study protocol for a randomised controlled trial
title_sort three donor site dressings in pediatric split-thickness skin grafts: study protocol for a randomised controlled trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335760/
https://www.ncbi.nlm.nih.gov/pubmed/25887128
http://dx.doi.org/10.1186/s13063-015-0557-9
work_keys_str_mv AT mcbridecraiga threedonorsitedressingsinpediatricsplitthicknessskingraftsstudyprotocolforarandomisedcontrolledtrial
AT kimbleroym threedonorsitedressingsinpediatricsplitthicknessskingraftsstudyprotocolforarandomisedcontrolledtrial
AT stocktonkellie threedonorsitedressingsinpediatricsplitthicknessskingraftsstudyprotocolforarandomisedcontrolledtrial